{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T06:33:05Z","timestamp":1793082785872,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T00:00:00Z","timestamp":1791590400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.ejphar.2026.179398","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:56:55Z","timestamp":1791475015000},"page":"179398","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Evaluation of EVT401, a P2X7 receptor antagonist, in healthy Chinese participants: a first-in-human, double-blind, randomized, placebo-controlled, dose-escalation trial"],"prefix":"10.1016","volume":"1037","author":[{"given":"Haimei","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingping","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xintong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianglin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaoxuan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanchen","family":"Niu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Ban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dajiang","family":"Qin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangbin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tenghua","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.ejphar.2026.179398_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25052495","article-title":"P2X7 receptor in dendritic cells and macrophages: implications in antigen presentation and T lymphocyte activation","volume":"25","author":"Acu\u00f1a-Castillo","year":"2024","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179398_bib2","doi-asserted-by":"crossref","first-page":"318","DOI":"10.4103\/NRR.NRR-D-24-01115","article-title":"P2X7 receptors and multiple sclerosis: a potential biomarker and therapeutic target?","volume":"21","author":"Agliardi","year":"2026","journal-title":"Neural Regen. Res."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179398_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-2125.2012.04320.x","article-title":"Pharmacokinetic and pharmacodynamic profiling of a P2X7 receptor allosteric modulator GSK1482160 in healthy human subjects","volume":"75","author":"Ali","year":"2013","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179398_bib4","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1124\/pr.113.008003","article-title":"The P2X7 receptor channel: recent developments and the use of P2X7 antagonists in models of disease","volume":"66","author":"Bartlett","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2026.179398_bib5","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.ejpb.2016.07.013","article-title":"Fed-state gastric media and drug analysis techniques: current status and points to consider","volume":"107","author":"Baxevanis","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179398_bib6","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.sjbs.2021.09.014","article-title":"Exploring the role of cathepsin in rheumatoid arthritis","volume":"29","author":"Behl","year":"2022","journal-title":"Saudi J. Biol. Sci."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179398_bib7","doi-asserted-by":"crossref","DOI":"10.1007\/s11051-024-05985-6","article-title":"Bile salts: unlocking the potential as bio-surfactant for enhanced drug absorption","volume":"26","author":"Chakravarthy","year":"2024","journal-title":"J. Nanoparticle Res."},{"issue":"17","key":"10.1016\/j.ejphar.2026.179398_bib8","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s40265-017-0832-z","article-title":"A review of food-drug interactions on oral drug absorption","volume":"77","author":"Deng","year":"2017","journal-title":"Drugs"},{"issue":"3","key":"10.1016\/j.ejphar.2026.179398_bib9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41423-019-0201-9","article-title":"ACPAs promote IL-1\u03b2 production in rheumatoid arthritis by activating the NLRP3 inflammasome","volume":"17","author":"Dong","year":"2020","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.ejphar.2026.179398_bib10","series-title":"Evotec Announces the Successful Completion of the First Phase I Study with EVT 401, an Oral P2X7 Receptor Antagonist - Very Good Safety Profile and Confirmed \"On Target Activity\"","year":"2009"},{"key":"10.1016\/j.ejphar.2026.179398_bib11","series-title":"Evotec Grants Exclusive Rights on EVT 401 in China to Conba Pharmaceutical","year":"2012"},{"key":"10.1016\/j.ejphar.2026.179398_bib12","doi-asserted-by":"crossref","DOI":"10.1038\/srep35804","article-title":"Involvement of P2X7 receptor signaling on regulating the differentiation of Th17 cells and type II collagen-induced arthritis in mice","volume":"6","author":"Fan","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.ejphar.2026.179398_bib13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3389\/fimmu.2019.00411","article-title":"P2RX7 deletion in T cells promotes autoimmune arthritis by unleashing the tfh cell response","volume":"10","author":"Felix","year":"2019","journal-title":"Front. Immunol."},{"issue":"18","key":"10.1016\/j.ejphar.2026.179398_bib14","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241814116","article-title":"The P2X7 receptor in autoimmunity","volume":"24","author":"Grassi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179398_bib15","doi-asserted-by":"crossref","first-page":"61","DOI":"10.22159\/ijap.2019v11i1.28664","article-title":"Effect of physicochemical properties of emulsions formed by self-emulsifying drug delivery systems (sedds) on the solubilization state of drug: in vitro study","volume":"11","author":"Hasan","year":"2019","journal-title":"Int. J. Appl. Pharm."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179398_bib16","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/s11302-021-09790-x","article-title":"Structural basis for the functional properties of the P2X7 receptor for extracellular ATP","volume":"17","author":"Jiang","year":"2021","journal-title":"Purinergic Signal."},{"issue":"10","key":"10.1016\/j.ejphar.2026.179398_bib17","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1136\/annrheumdis-2011-143578","article-title":"Clinical evaluation of the efficacy of the P2X7 purinergic receptor antagonist AZD9056 on the signs and symptoms of rheumatoid arthritis in patients with active disease despite treatment with methotrexate or sulphasalazine","volume":"71","author":"Keystone","year":"2012","journal-title":"Annals of the rheumatic diseases"},{"issue":"12","key":"10.1016\/j.ejphar.2026.179398_bib18","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1016\/j.bpj.2013.05.006","article-title":"Dual gating mechanism and function of P2X7 receptor channels","volume":"104","author":"Khadra","year":"2013","journal-title":"Biophys. J."},{"key":"10.1016\/j.ejphar.2026.179398_bib19","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3389\/fnmol.2019.00183","article-title":"P2X7 interactions and signaling - making head or tail of it","volume":"12","author":"Kopp","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.ejphar.2026.179398_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.947636","article-title":"Migration and homeostasis of regulatory T cells in rheumatoid arthritis","volume":"13","author":"Kotschenreuther","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.ejphar.2026.179398_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2020.114385","article-title":"P2X7 receptor and the NLRP3 inflammasome: partners in crime","volume":"187","author":"Pelegrin","year":"2021","journal-title":"Biochem. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejphar.2026.179398_bib22","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/s41573-024-00959-8","article-title":"Sequential immunotherapy: towards cures for autoimmunity","volume":"23","author":"Ram\u00edrez-Valle","year":"2024","journal-title":"Nat. Rev. Drug Discov."},{"issue":"21","key":"10.1016\/j.ejphar.2026.179398_bib23","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adw9543","article-title":"P2X7R of synovial fibroblasts is a potential therapeutic target associated with refractory rheumatoid arthritis","volume":"12","author":"Rao","year":"2026","journal-title":"Sci. Adv."},{"key":"10.1016\/j.ejphar.2026.179398_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.108858","article-title":"Emerging therapeutic potential of regulatory T (Treg) cells for rheumatoid arthritis: new insights and challenges","volume":"108","author":"Rezaei Kahmini","year":"2022","journal-title":"Int. Immunopharmacol."},{"issue":"14","key":"10.1016\/j.ejphar.2026.179398_bib25","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21144937","article-title":"P2X7 receptor at the crossroads of T cell fate","volume":"21","author":"Rivas-Y\u00e1\u00f1ez","year":"2020","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.ejphar.2026.179398_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14051116","article-title":"The role of purinergic P2X7 receptor in inflammation and cancer: novel molecular insights and clinical applications","volume":"14","author":"Rotondo","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.ejphar.2026.179398_bib27","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3389\/fphar.2018.00052","article-title":"The P2X7 receptor in inflammatory diseases: Angel or demon?","volume":"9","author":"Savio","year":"2018","journal-title":"Front. Pharmacol."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179398_bib28","doi-asserted-by":"crossref","first-page":"720","DOI":"10.3899\/jrheum.110874","article-title":"Efficacy and safety of CE-224,535, an antagonist of P2X7 receptor, in treatment of patients with rheumatoid arthritis inadequately controlled by methotrexate","volume":"39","author":"Stock","year":"2012","journal-title":"J. Rheumatol."},{"issue":"1","key":"10.1016\/j.ejphar.2026.179398_bib29","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13075-023-03041-7","article-title":"Stratified distribution of Th17 and Treg cells in patients with multi-stage rheumatoid arthritis","volume":"25","author":"Su","year":"2023","journal-title":"Arthritis Res. Ther."},{"issue":"12","key":"10.1016\/j.ejphar.2026.179398_bib30","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1177\/0269881118800067","article-title":"Clinical pharmacokinetics, pharmacodynamics, safety, and tolerability of JNJ-54175446, a brain permeable P2X7 antagonist, in a randomised single-ascending dose study in healthy participants","volume":"32","author":"Timmers","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.ejphar.2026.179398_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.841732","article-title":"Pyroptosis and its role in autoimmune disease: a potential therapeutic target","volume":"13","author":"You","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.ejphar.2026.179398_bib32","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1002\/jcp.27544","article-title":"P2X7, a critical regulator and potential target for bone and joint diseases","volume":"234","author":"Zeng","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"10.1016\/j.ejphar.2026.179398_bib33","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jpha.2017.03.008","article-title":"Identification and characterization of related substances in EVT-401 by hyphenated LC-MS techniques","volume":"7","author":"Zhu","year":"2017","journal-title":"Journal of pharmaceutical analysis"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926008800?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299926008800?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T05:37:19Z","timestamp":1793079439000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299926008800"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":33,"alternative-id":["S0014299926008800"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179398","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of EVT401, a P2X7 receptor antagonist, in healthy Chinese participants: a first-in-human, double-blind, randomized, placebo-controlled, dose-escalation trial","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2026.179398","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"179398"}}